PC
ANGO icon

Pier Capital’s AngioDynamics ANGO Stock Holding History

Pier Capital’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5M Buy
806,678
+9,982
+1% +$114K 1.39% 16
2026
Q1 		$9.06M Buy
796,696
+224,841
+39% +$2.44M 1.49% 12
2025
Q4 		$7.34M Sell
571,855
-91,357
-14% -$1.13M 1.17% 37
2025
Q3 		$7.41M Sell
663,212
-31,023
-4% -$299K 1.16% 34
2025
Q2 		$6.89M Buy
694,235
+200,244
+41% +$1.96M 1.05% 51
2025
Q1 		$4.64M Buy
+493,991
New +$5.19M 0.78% 64

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pier Capital's ANGO Position: Q2 2026 in Review

Pier Capital increased its AngioDynamics (ANGO) stake by 1.3% in Q2 2026, buying an estimated $114K and bringing the position to 806,678 shares worth $10.5M. The position accounts for 1.39% of the portfolio, ranked #16.

Pier Capital first reported a position in ANGO in Q1 2025 and has held it in 6 quarters since. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Pier Capital held 806,678 shares of AngioDynamics worth $10.5M as of Q2 2026.
  • Pier Capital bought 9,982 AngioDynamics shares in Q2 2026, an estimated $114K.
  • AngioDynamics made up 1.39% of Pier Capital's portfolio in Q2 2026, its #16 holding.
  • Pier Capital first reported a position in AngioDynamics in Q1 2025 and has held it in 6 quarters since.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Pier Capital's 13F filing for Q2 2026, filed 5 Aug 2026.